2-(1-HEXYLOXYETHYL)-2-DEVINYL PYROPHEOPHORBIDE-A
Trials 15
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 16 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 2-(1-hexyloxyethyl)-2 Devinyl Pyropheophorbide-a | “A Phase I/II Study of Photodynamic Therapy (PDT) Using 2-[1-hexyloxyethyl]-2-devinylpyropheophorbide-a (HPPH) for the Treatment of High Grade Dysplasia, Carcinoma-in-situ and...” NCT01236443 ↗6“OBJECTIVES: To determine the safety of photodynamic therapy with 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH) in combination with surgery in patients with head and...” PMID 23868427 ↗ Jul 2013 “A Phase I Study Of Photodynamic Therapy (PDT) For The Treatment Of Basal Cell Carcinoma (BCC): A Drug/Light Dose Finding Study Utilizing 2-(1-HEXYLOXYETHYL)-2-DEVINYL...” NCT00017485 ↗ “Phase I Trial of Photodynamic Therapy With HPPH (2-1[Hexyloxyethyl]-2-devinylpyropheophorbide-a) for Treatment of Dysplasia, Carcinoma in Situ and Stage I Carcinoma of the Oral Cavity” NCT00670397 ↗ “Phase I Trial of Photodynamic Therapy With HPPH (2-1[Hexyloxyethyl]-2-devinylpyropheophorbide-a) for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Larynx” NCT00675233 ↗ “A Phase I Study of Photodynamic Therapy (PDT) Using 2-(1-hexyloxyethyl)-2 Devinyl Pyropheophorbide-a (HPPH) for Treatment of Early Stage Lung Cancer - A Dose Ranging Study” NCT00025571 ↗ “photosensitizer (PS) 2-\[1-hexyloxyethyl\]-2-devinyl pyropheophorbide-a (HPPH) for injection” NCT03757754 ↗ |
| Known as | 2-[1-hydroxyethyl]-2-devinylpyropheophorbide-a | “A Study to identify toxicity and optimal photodynamic treatment parameters using the photosensitizer 2-[1-hydroxyethyl]-2-devinylpyropheophorbide-a (HPPH) in high grade...” NCT01236443 ↗ |
| Known as | HPPH | “Patients will be given HPPH, by intravenous injection prior to surgery.” NCT01673074 ↗ |
| Known as | HPPH-PHOTOCLOR | “A Phase I Study Of Photodynamic Therapy (PDT) For The Treatment Of Basal Cell Carcinoma (BCC): A Drug/Light Dose Finding Study Utilizing 2-(1-HEXYLOXYETHYL)-2-DEVINYL...” NCT00017485 ↗ |
| Modality | Other / unclassified | “using the photosensitizer 2-[1-hydroxyethyl]-2-devinylpyropheophorbide-a (HPPH)” NCT01236443 ↗ |
| Route | Intravenous | “Patients receive HPPH IV on day 1.” NCT00017485 ↗ |